121 related articles for article (PubMed ID: 29039346)
1. Astrogliosis has Different Dynamics after Cell Transplantation and Mechanical Impact in the Rodent Model of Parkinson's Disease.
Tomov N; Surchev L; Wiedenmann C; Döbrössy MD; Nikkhah G
Balkan Med J; 2018 Mar; 35(2):141-147. PubMed ID: 29039346
[TBL] [Abstract][Full Text] [Related]
2. A microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology.
Nikkhah G; Olsson M; Eberhard J; Bentlage C; Cunningham MG; Björklund A
Neuroscience; 1994 Nov; 63(1):57-72. PubMed ID: 7898661
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic reinnervation of the globus pallidus by fetal nigral grafts in the rodent model of Parkinson's disease.
Bartlett LE; Mendez I
Cell Transplant; 2005; 14(2-3):119-27. PubMed ID: 15881421
[TBL] [Abstract][Full Text] [Related]
4. Roscovitine, an experimental CDK5 inhibitor, causes delayed suppression of microglial, but not astroglial recruitment around intracerebral dopaminergic grafts.
Tomov N; Surchev L; Wiedenmann C; Döbrössy M; Nikkhah G
Exp Neurol; 2019 Aug; 318():135-144. PubMed ID: 31028828
[TBL] [Abstract][Full Text] [Related]
5. A novel strategy for intrastriatal dopaminergic cell transplantation: sequential "nest" grafting influences survival and behavioral recovery in a rat model of Parkinson's disease.
Timmer M; Nikkhah G
Exp Cell Res; 2012 Dec; 318(20):2531-42. PubMed ID: 23010385
[TBL] [Abstract][Full Text] [Related]
6. Olfactory ensheathing glial co-grafts improve functional recovery in rats with 6-OHDA lesions.
Johansson S; Lee IH; Olson L; Spenger C
Brain; 2005 Dec; 128(Pt 12):2961-76. PubMed ID: 16251218
[TBL] [Abstract][Full Text] [Related]
7. Astrocytes promote or impair the survival and function of embryonic ventral mesencephalon co-grafts: effects of astrocyte age and expression of recombinant brain-derived neurotrophic factor.
Krobert K; Lopez-Colberg I; Cunningham LA
Exp Neurol; 1997 Jun; 145(2 Pt 1):511-23. PubMed ID: 9217087
[TBL] [Abstract][Full Text] [Related]
8. Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons.
Terpstra BT; Collier TJ; Marchionini DM; Levine ND; Paumier KL; Sortwell CE
J Neurosci Methods; 2007 Oct; 166(1):13-9. PubMed ID: 17706789
[TBL] [Abstract][Full Text] [Related]
9. A comparison of solid intraventricular and dissociated intraparenchymal fetal substantia nigra grafts in a rat model of Parkinson's disease: impaired graft survival is associated with high baseline rotational behavior.
Heim RC; Willingham G; Freed WJ
Exp Neurol; 1993 Jul; 122(1):5-15. PubMed ID: 8101821
[TBL] [Abstract][Full Text] [Related]
10. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease.
Höglinger GU; Widmer HR; Spenger C; Meyer M; Seiler RW; Oertel WH; Sautter J
Exp Neurol; 2001 Jan; 167(1):148-57. PubMed ID: 11161602
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of mesencephalic cell suspension in dopamine-denervated striatum of the rat.I. Effects on spontaneous activity of striatal neurons.
Di Loreto S; Florio T; Capozzo A; Napolitano A; Adorno D; Scarnati E
Exp Neurol; 1996 Apr; 138(2):318-26. PubMed ID: 8620930
[TBL] [Abstract][Full Text] [Related]
12. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease.
Kordower JH; Freeman TB; Snow BJ; Vingerhoets FJ; Mufson EJ; Sanberg PR; Hauser RA; Smith DA; Nauert GM; Perl DP
N Engl J Med; 1995 Apr; 332(17):1118-24. PubMed ID: 7700284
[TBL] [Abstract][Full Text] [Related]
13. BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons.
Yurek DM; Lu W; Hipkens S; Wiegand SJ
Exp Neurol; 1996 Jan; 137(1):105-18. PubMed ID: 8566202
[TBL] [Abstract][Full Text] [Related]
14. Human fetal neocortical tissue grafted to rat brain cavities survives, leads to reciprocal nerve fiber growth, and accumulates host IgG.
Humpel C; Bygdeman M; Olson L; Strömberg I
J Comp Neurol; 1994 Feb; 340(3):337-48. PubMed ID: 7910615
[TBL] [Abstract][Full Text] [Related]
15. Effects of intranigral vs intrastriatal fetal mesencephalic neural grafts on motor behavior disorders in a rat Parkinson model.
Goren B; Kahveci N; Eyigor O; Alkan T; Korfali E; Ozluk K
Surg Neurol; 2005; 64 Suppl 2():S33-41. PubMed ID: 16256839
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous Transplantation of Fetal Ventral Mesencephalic Tissue and Encapsulated Genetically Modified Cells Releasing GDNF in a Hemi-Parkinsonian Rat Model of Parkinson's Disease.
Perez-Bouza A; Di Santo S; Seiler S; Meyer M; Andereggen L; Huber A; Guzman R; Widmer HR
Cell Transplant; 2017 Sep; 26(9):1572-1581. PubMed ID: 29113462
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease.
Quinn M; Mukhida K; Sadi D; Hong M; Mendez I
Eur J Neurosci; 2008 Jan; 27(1):43-52. PubMed ID: 18093176
[TBL] [Abstract][Full Text] [Related]
18. Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease.
Vinuela A; Hallett PJ; Reske-Nielsen C; Patterson M; Sotnikova TD; Caron MG; Gainetdinov RR; Isacson O
Brain; 2008 Dec; 131(Pt 12):3361-79. PubMed ID: 18988638
[TBL] [Abstract][Full Text] [Related]
19. A multiple target neural transplantation strategy for Parkinson's disease.
Ramachandran AC; Bartlett LE; Mendez IM
Rev Neurosci; 2002; 13(3):243-56. PubMed ID: 12405227
[TBL] [Abstract][Full Text] [Related]
20. Evidence for target-specific outgrowth from subpopulations of grafted human dopamine neurons.
Strömberg I; Törnqvist N; Johansson S; Bygdeman M; Almqvist PM
Microsc Res Tech; 2001 Sep; 54(5):287-97. PubMed ID: 11514985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
